Dataset Viewer
Auto-converted to Parquet
peptide
stringlengths
8
15
label
float64
0
1
HLA
stringclasses
161 values
HLA_sequence
stringclasses
152 values
AAAAFEAAL
0.527533
HLA-C14:02
YSAGYREKYRQTDVSNLYLWFDSYTWAERAYTWY
AAAAFEAAL
0.522653
HLA-B48:01
YYSEYREISTNTYESNLYLSYNYYSLAVLAYEWY
AAAAMFAGE
0.01
HLA-B53:01
YYATYRNIFTNTYENIAYIRYDSYTWAVLAYLWY
AAAANTTAL
0.407702
HLA-C14:02
YSAGYREKYRQTDVSNLYLWFDSYTWAERAYTWY
AAAANTTAL
0.313449
HLA-C05:01
YYAGYREKYRQTDVNKLYLRYNFYTWAERAYTWY
AAAANTTAL
1
HLA-C03:03
YYAGYREKYRQTDVSNLYIRYDYYTWAELAYLWY
AAAANTTAL
0.563901
HLA-B07:02
YYSEYRNIYAQTDESNLYLSYDYYTWAERAYEWY
AAAAPYAGW
0.695046
HLA-B58:01
YYATYGENMASTYENIAYIRYDSYTWAVLAYLWY
AAAARSTSP
0.01
HLA-B57:03
YYAMYGENMASTYENIAYIVYNYYTWAVLAYLWY
AAAATCALV
0.752211
HLA-A02:02
YFAMYGEKVAHTHVDTLYLRYHYYTWAVWAYTWY
AAAATCALV
0.796413
HLA-A02:03
YFAMYGEKVAHTHVDTLYVRYHYYTWAEWAYTWY
AAAATCALV
0.656779
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAATCALV
0.770337
HLA-A02:06
YYAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAATCALV
0.772714
HLA-A68:02
YYAMYRNNVAQTDVDTLYIRYHYYTWAVWAYTWY
AAAATSAGTR
0.253411
HLA-A11:01
YYAMYQENVAQTDVDTLYIIYRDYTWAAQAYRWY
AAADFAHAE
0.04416
HLA-B44:03
YYTKYREISTNTYENTAYIRYDDYTWAVLAYLSY
AAAEVAGAL
0
HLA-B35:01
YYATYRNIFTNTYESNLYIRYDSYTWAVLAYLWY
AAAEVAGAL
0.194283
HLA-B07:02
YYSEYRNIYAQTDESNLYLSYDYYTWAERAYEWY
AAAEVAGAL
0.001205
HLA-B44:03
YYTKYREISTNTYENTAYIRYDDYTWAVLAYLSY
AAAFPGLA
0.01
HLA-B81:01
YYSEYRNIYAQTDESNLYLSYNYYSLAVLAYEWY
AAAFVNQHL
0.212499
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAFVNQHLC
0
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAGSTTSV
0.084687
HLA-B07:02
YYSEYRNIYAQTDESNLYLSYDYYTWAERAYEWY
AAAGTALAT
0.01
HLA-A23:01
YSAMYEEKVAHTDENIAYLMFHYYTWAVLAYTGY
AAAGTALAT
0.01
HLA-A24:02
YSAMYEEKVAHTDENIAYLMFHYYTWAVQAYTGY
AAAIVGQDGS
0.01
HLA-A02:50
YFAMYGEKVAHTHVDTLYIRYHYYTWAVWAYTWY
AAAKAAAAV
0.740346
HLA-A02:02
YFAMYGEKVAHTHVDTLYLRYHYYTWAVWAYTWY
AAAKAAAAV
0.54141
HLA-A02:03
YFAMYGEKVAHTHVDTLYVRYHYYTWAEWAYTWY
AAAKAAAAV
0.449853
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAKAAAAV
0.641444
HLA-A02:05
YYAMYGEKVAHTHVDTLYLRYHYYTWAVWAYTWY
AAAKAAAAV
0.639678
HLA-A02:06
YYAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAKAAAAV
0.550817
HLA-A68:02
YYAMYRNNVAQTDVDTLYIRYHYYTWAVWAYTWY
AAAKTPVIV
0.302386
HLA-A02:02
YFAMYGEKVAHTHVDTLYLRYHYYTWAVWAYTWY
AAAKTPVIV
0.32917
HLA-A02:03
YFAMYGEKVAHTHVDTLYVRYHYYTWAEWAYTWY
AAAKTPVIV
0.033761
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAKTPVIV
0
HLA-A02:06
YYAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAKTPVIV
0.29658
HLA-A68:02
YYAMYRNNVAQTDVDTLYIRYHYYTWAVWAYTWY
AAAKTPVIVV
0.168935
HLA-A02:02
YFAMYGEKVAHTHVDTLYLRYHYYTWAVWAYTWY
AAAKTPVIVV
0.323046
HLA-A02:03
YFAMYGEKVAHTHVDTLYVRYHYYTWAEWAYTWY
AAAKTPVIVV
0.011187
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAKTPVIVV
0.121997
HLA-A02:06
YYAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAKTPVIVV
0.208321
HLA-A68:02
YYAMYRNNVAQTDVDTLYIRYHYYTWAVWAYTWY
AAALAGCGS
0.01
HLA-A02:16
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYEWY
AAALLTSSYY
0.01
HLA-A03:19
YFAMYQENVAQTDVDTLYIIFHYYTWAELAYTWY
AAALRDAQM
0.01
HLA-C07:01
YDSGYRENYRQADVSNLYLRYDSYTLAALAYTWY
AAALTQND
0.01
HLA-A03:19
YFAMYQENVAQTDVDTLYIIFHYYTWAELAYTWY
AAAPKPVV
0.01
HLA-B57:03
YYAMYGENMASTYENIAYIVYNYYTWAVLAYLWY
AAAQGQAPL
0.084687
HLA-A80:01
YFAMYEENVAHTNANTLYIIYRDYTWARLAYEGY
AAAQGQAPL
0.084687
HLA-A02:11
YFAMYGEKVAHIDVDTLYVRYHYYTWAVLAYTWY
AAAQGQAPL
0.084687
HLA-A02:03
YFAMYGEKVAHTHVDTLYVRYHYYTWAEWAYTWY
AAAQGQAPL
0.084687
HLA-A02:16
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYEWY
AAAQGQAPL
0.084687
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAQGQAPL
0.084687
HLA-A02:19
YFAMYGEKVAHTHVDTLYVRYHYYTWAVQAYTGY
AAAQGQAPL
0.084687
HLA-A02:12
YFAMYGEKVAHTHVDTLYVRYHYYTWAVQAYTWY
AAAQGQAPL
0.084687
HLA-A03:01
YFAMYQENVAQTDVDTLYIIYRDYTWAELAYTWY
AAAQGQAPL
0.084687
HLA-B18:01
YHSTYRNISTNTYESNLYLRYDSYTWAVLAYTWH
AAAQGQAPL
0.084687
HLA-B27:03
YHTEHREICAKTDEDTLYLNYHDYTWAVLAYEWY
AAAQGQAPL
0.43935
HLA-C14:02
YSAGYREKYRQTDVSNLYLWFDSYTWAERAYTWY
AAAQGQAPL
0.084687
HLA-A23:01
YSAMYEEKVAHTDENIAYLMFHYYTWAVLAYTGY
AAAQGQAPL
0.084687
HLA-A24:03
YSAMYEEKVAHTDENIAYLMFHYYTWAVQAYTWY
AAAQGQAPL
0.084687
HLA-A29:02
YTAMYLQNVAQTDANTLYIMYRDYTWAVLAYTWY
AAAQGQAPL
0.084687
HLA-B57:01
YYAMYGENMASTYENIAYIVYDSYTWAVLAYLWY
AAAQGQAPL
0.084687
HLA-A26:01
YYAMYRNNVAHTDANTLYIRYQDYTWAEWAYRWY
AAAQGQAPL
0.084687
HLA-A25:01
YYAMYRNNVAHTDESIAYIRYQDYTWAEWAYRWY
AAAQGQAPL
0.084687
HLA-A69:01
YYAMYRNNVAQTDVDTLYVRYHYYTWAVLAYTWY
AAAQGQAPL
0.084687
HLA-B51:01
YYATYRNIFTNTYENIAYWTYNYYTWAELAYLWH
AAAQGQAPL
0.084687
HLA-B39:01
YYSEYRNICTNTDESNLYLRYNFYTWAVLTYTWY
AAAQGQAPL
0.741466
HLA-B07:02
YYSEYRNIYAQTDESNLYLSYDYYTWAERAYEWY
AAAQKAALK
0.01
HLA-A33:01
YTAMYRNNVAHIDVDTLYIMYQDYTWAVLAYTWH
AAAQKAALK
0.01
HLA-A66:01
YYAMYRNNVAQTDVDTLYIRYQDYTWAEWAYRWY
AAAQKPSSTQ
0.01
HLA-C14:02
YSAGYREKYRQTDVSNLYLWFDSYTWAERAYTWY
AAARNQLQ
0.01
HLA-B27:05
YHTEYREICAKTDEDTLYLNYHDYTWAVLAYEWY
AAASAVVF
0.01
HLA-B08:01
YDSEYRNIFTNTDESNLYLSYNYYTWAVDAYTWY
AAASAVVF
0.01
HLA-B07:02
YYSEYRNIYAQTDESNLYLSYDYYTWAERAYEWY
AAASSLLYK
0
HLA-A02:02
YFAMYGEKVAHTHVDTLYLRYHYYTWAVWAYTWY
AAASSLLYK
0.031401
HLA-A02:03
YFAMYGEKVAHTHVDTLYVRYHYYTWAEWAYTWY
AAASSLLYK
0
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAASSLLYK
0.780368
HLA-A03:01
YFAMYQENVAQTDVDTLYIIYRDYTWAELAYTWY
AAASSLLYK
0.488861
HLA-A31:01
YTAMYQENVAHIDVDTLYIMYQDYTWAVLAYTWY
AAASSLLYK
0.153147
HLA-A33:01
YTAMYRNNVAHIDVDTLYIMYQDYTWAVLAYTWH
AAASSLLYK
0.010608
HLA-A02:06
YYAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAASSLLYK
0.748583
HLA-A11:01
YYAMYQENVAQTDVDTLYIIYRDYTWAAQAYRWY
AAASSLLYK
0.573507
HLA-A68:01
YYAMYRNNVAQTDVDTLYIMYRDYTWAVWAYTWY
AAASSLLYK
0
HLA-A68:02
YYAMYRNNVAQTDVDTLYIRYHYYTWAVWAYTWY
AAASSTHRKV
0
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAASTAASGSA
0.01
HLA-A26:02
YYAMYRNNVAHTDANTLYIRYQNYTWAEWAYRWY
AAATILTS
0.01
HLA-A02:17
YFAMYGEKVAHTHVDTLYLMFHYYTWAVLAYTWY
AAATSAGTR
0.231444
HLA-A11:01
YYAMYQENVAQTDVDTLYIIYRDYTWAAQAYRWY
AAATSAGTRR
0.341356
HLA-A11:01
YYAMYQENVAQTDVDTLYIIYRDYTWAAQAYRWY
AAAVAYPEL
0.260241
HLA-C14:02
YSAGYREKYRQTDVSNLYLWFDSYTWAERAYTWY
AAAVAYPEL
0.084687
HLA-C05:01
YYAGYREKYRQTDVNKLYLRYNFYTWAERAYTWY
AAAVAYPEL
0.935937
HLA-C03:03
YYAGYREKYRQTDVSNLYIRYDYYTWAELAYLWY
AAAVAYPEL
0.084687
HLA-B58:01
YYATYGENMASTYENIAYIRYDSYTWAVLAYLWY
AAAVAYPEL
0.084687
HLA-B39:01
YYSEYRNICTNTDESNLYLRYNFYTWAVLTYTWY
AAAVWIQVRV
0.01
HLA-B27:03
YHTEHREICAKTDEDTLYLNYHDYTWAVLAYEWY
AAAWGGSGS
0.85125
HLA-A30:02
YSAMYQENVAHTDENTLYIIYEHYTWARLAYTWY
AAAWYLWEV
0.329153
HLA-A02:17
YFAMYGEKVAHTHVDTLYLMFHYYTWAVLAYTWY
AAAWYLWEV
1
HLA-A02:01
YFAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAWYLWEV
0.88744
HLA-A02:06
YYAMYGEKVAHTHVDTLYVRYHYYTWAVLAYTWY
AAAWYLWEVK
0.294767
HLA-A32:01
YFAMYQENVAHTDESIAYIMYQDYTWAVLAYTWY
End of preview. Expand in Data Studio

Modality OOD Dataset

Dataset Description

The Modality OOD dataset tests model generalization across different data modalities in peptide-MHC (pMHC) binding prediction. It contains two complementary datasets representing distinct experimental measurement types:

  • BA (Binding Affinity): In vitro binding affinity measurements with continuous values
  • EL (Eluted Ligand): Mass spectrometry-based eluted ligand data with binary labels

Key Features

  • Modality Shift Testing: Evaluates if models trained on one modality (e.g., BA) can generalize to another (e.g., EL)
  • Real-World Relevance: Reflects the practical challenge of applying models across different experimental platforms
  • Large Scale: Combined 3.85M samples across 130+ HLA alleles
  • Single Allele Format: Each sample has one peptide-HLA pair (no multi-allele)

Biological Significance

Why Two Modalities Matter:

  1. Binding Affinity (BA):

    • Measures peptide-MHC binding strength in controlled conditions
    • Continuous scale (0 = no binding, 1 = strong binding)
    • Reflects thermodynamic stability
    • Common in immunoinformatics training data
  2. Eluted Ligand (EL):

    • Peptides naturally presented on cell surface MHC molecules
    • Binary label (1 = naturally presented, 0 = not presented)
    • Reflects cellular processing, TAP transport, and MHC loading
    • More biologically relevant but harder to obtain

The Modality Gap: Models trained on BA data often fail on EL data (and vice versa) because:

  • BA measures binding only, EL captures the full antigen processing pathway
  • Different experimental biases and noise profiles
  • Label semantics differ (affinity vs. presentation)

This dataset enables testing cross-modality generalization.

Dataset Structure

Files

  • ba_s.csv: Binding Affinity dataset (single allele)
  • el_s.csv: Eluted Ligand dataset (single allele)

Data Format

Both files share the same schema:

Column Type Description Required
peptide string Peptide amino acid sequence (8-15aa) Yes
HLA string HLA allele (e.g., HLA-A02:01, HLA-B07:02) Yes
label float/int BA: continuous 0-1, EL: binary 0/1 Yes
HLA_sequence string HLA pseudo-sequence Yes

Dataset Statistics

BA (Binding Affinity)

  • Total Samples: 170,470
  • Label Type: Continuous (0.0 to 1.0)
  • Mean Affinity: 0.2547
  • Median Affinity: 0.0847
  • Unique HLA Alleles: 111
  • Peptide Lengths: 8-14 amino acids (74.3% are 9-mers)
  • File Size: 10.61 MB

EL (Eluted Ligand)

  • Total Samples: 3,679,405
  • Label Type: Binary classification
  • Positive Samples: 197,547 (5.4%)
  • Negative Samples: 3,481,858 (94.6%)
  • Unique HLA Alleles: 130
  • Peptide Lengths: 8-15 amino acids (distributed across all lengths)
  • File Size: 213.35 MB

Combined Statistics

  • Total Samples: 3,849,875
  • Unique HLA Coverage: 130+ alleles across HLA-A, B, C
  • Modalities: 2 (BA and EL)
  • Task Type: Peptide-MHC (PM) binding prediction

Usage

Load with Pandas

from huggingface_hub import hf_hub_download
import pandas as pd

# Download BA dataset
ba_file = hf_hub_download(
    repo_id="YYJMAY/modality-ood",
    filename="ba_s.csv",
    repo_type="dataset"
)
ba_df = pd.read_csv(ba_file)

# Download EL dataset
el_file = hf_hub_download(
    repo_id="YYJMAY/modality-ood",
    filename="el_s.csv",
    repo_type="dataset"
)
el_df = pd.read_csv(el_file)

Use with SPRINT Framework

from sprint.core.dataset_manager import DatasetManager

manager = DatasetManager()
config = {
    'hf_repo': 'YYJMAY/modality-ood',
    'files': ['ba_s.csv', 'el_s.csv'],
    'ba': 'ba_s.csv',
    'el': 'el_s.csv'
}

files = manager.get_dataset('modality_ood', config)
ba_file = files['ba']
el_file = files['el']

Example: Cross-Modality Evaluation

import pandas as pd
from your_model import YourModel

# Load data
ba_df = pd.read_csv(ba_file)
el_df = pd.read_csv(el_file)

# Scenario 1: Train on BA, test on EL
model = YourModel()
model.train(ba_df)
el_predictions = model.predict(el_df)

# Scenario 2: Train on EL, test on BA
model = YourModel()
model.train(el_df)
ba_predictions = model.predict(ba_df)

# Evaluate cross-modality generalization

Experimental Design

Recommended Evaluation Scenarios

  1. BA → EL Generalization

    • Train on BA (continuous labels)
    • Test on EL (binary labels)
    • Measures if affinity-based models predict presentation
  2. EL → BA Generalization

    • Train on EL (binary labels)
    • Test on BA (continuous labels)
    • Measures if presentation-based models predict affinity
  3. Mixed Training

    • Train on both BA and EL
    • Test separately on each
    • Measures multi-task learning benefits
  4. Modality-Specific Training

    • Train and test on same modality
    • Baseline for comparison

Metrics Considerations

  • For BA: Use regression metrics (MSE, MAE, Pearson correlation)
  • For EL: Use classification metrics (AUC, F1, precision, recall)
  • Cross-modal: May need to binarize BA predictions or convert EL to scores

Construction Method

Both datasets were constructed to ensure:

  1. Single Allele Format: Each sample has exactly one HLA allele
  2. Quality Control:
    • No missing values in required columns
    • No duplicate peptide-HLA-label combinations
    • Peptide lengths filtered to 8-15 amino acids
  3. Standardized HLA Format: HLA-A02:01 format (with hyphen prefix)
  4. Representative Coverage: 130+ HLA alleles across major supertypes
  5. Balanced Lengths: Both datasets include diverse peptide lengths

Citation

If you use this dataset, please cite:

@dataset{modality_ood_2024,
  title={Modality OOD Dataset for Peptide-MHC Binding Prediction},
  author={SPRINT Framework Contributors},
  year={2024},
  url={https://huggingface.co/datasets/YYJMAY/modality-ood}
}

Related Datasets

  • Allelic OOD: Tests generalization to rare HLA alleles
  • Temporal OOD: Tests generalization to new data over time

Notes

  • No CDR3 sequences: These datasets are for PM (Peptide-MHC) tasks only, not PMT (Peptide-MHC-TCR)
  • Label semantics differ: BA is continuous affinity, EL is binary presentation
  • Experimental platforms differ: BA from in vitro assays, EL from mass spectrometry
  • Biological processes differ: BA measures binding only, EL captures full pathway

License

MIT License

Contact

For questions or issues, please open an issue on the dataset repository.


Keywords: peptide-MHC binding, immunology, binding affinity, eluted ligand, modality shift, out-of-distribution, generalization, cross-modal learning

Downloads last month
16